Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
GLYCOLIPID DERIVATIVES, PROCESS FOR PRODUCTION OF THE SAME, INTERMEDIATES FOR SYNTHESIS THEREOF, AND PROCESS FOR PRODUCTION OF THE INTERMEDIATES
Document Type and Number:
WIPO Patent Application WO/2004/072091
Kind Code:
A1
Abstract:
Novel glycolipid derivatives wherein the substituent of the sphingosine base moiety is alkyl having a shorter carbon chain, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted aralkyl; an efficient process for mass-producing the same economically; and intermediates useful in the production thereof. Specifically, glycolipid derivatives represented by the general formula (I) are chemically synthesized: (I) wherein R3 is substituted or unsubstituted linear alkyl having 1 to 7 carbon atoms, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted aralkyl; and R8 is substituted or unsubstituted alkyl having 1 to 35 carbon atoms, substituted or unsubstituted aryl, or substituted or unsubstituted aralkyl.

Inventors:
ANNOURA HIROKAZU (JP)
MURATA KENJI (JP)
YAMAMURA TAKASHI (JP)
Application Number:
PCT/JP2004/001566
Publication Date:
August 26, 2004
Filing Date:
February 13, 2004
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
DAIICHI SUNTORY PHARMA CO LTD (JP)
JAPAN GOVERNMENT (JP)
ANNOURA HIROKAZU (JP)
MURATA KENJI (JP)
YAMAMURA TAKASHI (JP)
International Classes:
A61P37/02; C07C247/04; C07D317/28; C07H15/04; C07H15/26; (IPC1-7): C07H15/04; C07H15/26; A61K31/7032; A61P37/02; C07C247/04; C07C247/10; C07D317/28
Domestic Patent References:
WO1994009020A11994-04-28
WO1993005055A11993-03-18
WO2003016326A12003-02-27
Other References:
MIYAMOTO KATSUICHI ET AL.: "A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells", NATURE, vol. 413, no. 6855, 4 October 2001 (2001-10-04), pages 531 - 534, XP002958968
MIYAKE SACHIKO: "NKT saibo to jikkenteki jiko men'ekisei no sekizuien", INFLAMMATION & IMMUNOLOGY, vol. 10, no. 5, 20 August 2002 (2002-08-20), pages 501 - 506, XP002980517
MIYAKE SACHIKO ET AL.: "NTK saibo toshishitsu ligand ni yoru jiko men'ekisei shikkan seigyo", KABUSHIKI KAISHA CHUNGAI IGAKUSHA, 5 December 2002 (2002-12-05), pages 71 - 77, XP002980520
AYAD TAHAR ET AL.: "A new diorganozinc-based enantio-selective access to truncated D-ribophytosphingosine", TETRAHEDRON LETTERS, vol. 44, no. 3, 13 January 2003 (2003-01-13), pages 579 - 582, XP004399526
MORITA MASAHIRO ET AL.: "Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice", JOURNAL OF MEDICINAL CHEMISTRY, vol. 38, no. 12, 9 June 1995 (1995-06-09), pages 2176 - 2187, XP002919134
BROSSAY LAURENT ET AL.: "Cutting edge:structural requirements for galactosylceramide recognition by CD1-restricted NK T cells", JOURNAL OF IMMUNOLOGY, vol. 161, no. 10, 15 November 1998 (1998-11-15), pages 5124 - 5128, XP002980526
CHIU HSIN-YI ET AL.: "A facile synthesis of phyto-sphingosine from diisopropylidene-D-mannofuranose", JOURNAL OF ORGANIC CHEMISTRY, vol. 68, no. 14, 11 July 2003 (2003-07-11), pages 5788 - 5791, XP002980527
KAWANO TETSU ET AL.: "Natural killer-like non-specific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells", PROCEEDINGS OF THE NQTURQL QCQDEMY OF SCIENCES OF THE USA, vol. 95, no. 10, 12 May 1998 (1998-05-12), pages 5690 - 5693, XP002980528
See also references of EP 1619199A4
Attorney, Agent or Firm:
Aoki, Atsushi (Ishida & Associates Toranomon 37 Mori Bldg., 5-1, Toranomon 3-chom, Minato-ku Tokyo 23, JP)
Download PDF: